Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy and Radiation Therapy With or Without Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
This study is ongoing, but not recruiting participants.
Study NCT00503776 Information provided by National Cancer Institute (NCI)
First Received: July 17, 2007 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chemotherapeutic Agent Toxicity
Dysphagia
Head and Neck Cancer
Mucositis
Radiation Toxicity
Xerostomia
Additional conditions recognized in this trial
Deglutition Disorders
Head and Neck Neoplasms
More general conditions related to this trial
Digestive System Diseases
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Mouth Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Pharyngeal Diseases
Salivary Gland Diseases
Stomatognathic Diseases
Interventions listed in this trial
exercise intervention
amifostine trihydrate
therapeutic dietary intervention
Additional drug interventions recognized in this trial
Amifostine
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Sponsors listed in this trial
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
